Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status
This article is protected by copyright. All rights reserved.
We investigated the difference in striatal dopamine D2 receptor binding, as measured by PET with (N‐[11C]methyl)benperidol ([11C]NMB), between A1 allele carriers (A1+) and individuals homozygous for the A2 allele (A1‐) of the DRD2/ANKK1 TaqIA single nucleotide polymorphism. In Study 1, A1+ had 5‐12% less striatal [11C]NMB binding than A1‐.
Source: Synapse - Category: Neurology Authors: Sarah A. Eisenstein, Ryan Bogdan, Latisha Love‐Gregory, Nadia S. Corral‐Frías, Jonathan M. Koller, Kevin J. Black, Stephen M. Moerlein, Joel S. Perlmutter, Deanna M. Barch, Tamara Hershey Tags: Research Article Source Type: research
More News: Eating Disorders & Weight Management | Neurology | Obesity | PET Scan | Schizophrenia | Study